Are Louisiana Pharmacists PrEPared? Implementing Training and an Active PrEP (Pre-Exposure Prophylaxis) Prescribing Surveillance Program

NCT06530225 | Not Yet Recruiting DMC

• 1 other identifier: IRB1014-25
• Study Type: observational
• Target: 75
• Locations: 1 country
• Sites: 1

Brief Summary

Though broadening PrEP (Pre-Exposure Prophylaxis) availability to Louisiana pharmacies addresses key access issues for Louisiana's population, there is no current baseline data which explore current pharmacist and pharmacies' capacity to effectively provide PrEP therapy to patients who meet PrEP prescribing criteria. This study aims to explore1) Louisiana pharmacist and pharmacy capacity to provide PrEP under a state-based collaborative practice agreement, 2) a validated pharmacist education system addressing health disparities in PrEP prescribing and 3) the impact of state pharmacy based policies on equitable PrEP prescribing. Our central hypothesis is pharmacist trained in PrEP prescribing focusing on health disparities and implicit bias education and working with mentors in an implementation framework will have an increase in equitable PrEP prescribing

Conditions

HIV Prevention

Keywords

PrEP, HIV Prevention

Outcome Measures

Primary Outcomes (2)

• PrEP Prescribing

  Number of PrEP prescriptions dispensed from pharmacy (Scale PrEP prescription/1,000 total prescriptions in 30 day period)

  May 1, 2025- April 30, 2029

• Pharmacists' Knowledge and Confidence in PrEP prescribing

  Pharmacists will complete a pre and post-test on knowledge and confidence in PrEP prescribing to target populations. Knowledge will be scored on a graded scale of 0 (lowest to 100 (highest). Confidence will be scored on a Likert Scale (1 - least confident, 5 most confident)

  May 1, 2025- April 30, 2026

Study Arms (1)

Community Based Pharmacies

Community based pharmacies throughout Louisiana will be enrolled in a cohort of trained pharmacies for PrEP prescriptions for patients seeking HIV prevention medication.

Other: Education and Mentoring for Prescribing Pharmacists

Interventions

Education and Mentoring for Prescribing Pharmacists OTHER

Pharmacists enrolled in the PrEP prescribing cohort will receive implicit bias, health disparity and health equity training for HIV prevention. In addition, the pharmacists will receive mentorship and receive an implementation toolkit on best practices for PrEP prescribing.

Community Based Pharmacies

Eligibility Criteria

• Age: 24 Years - 99 Years
• Sex: all
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

All practicing community pharmacists who are interested in a PrEP education course on equitable PrEP prescribing to address health disparities among the target patient population.

You may qualify if:

• Community pharmacists in Louisiana providing PrEP prescriptions.

You may not qualify if:

• None

Sponsors & Collaborators

• Xavier University of Louisiana.: lead
• Louisiana Public Health Institute: collaborator

Study Sites (1)

Xavier University of Louisiana

New Orleans, Louisiana, 70125, United States

Location

MeSH Terms

Interventions

Educational Status

Intervention Hierarchy (Ancestors)

Socioeconomic Factors; Population Characteristics

Central Study Contacts

Sara Al-Dahir, PharmD, PhD

CONTACT

504-520-5766; saaldah@xula.edu

Ibrahim Hamed, BSc

CONTACT

504-520-4537; ihamed@xula.edu

Study Design

• Study Type: observational
• Observational Model: ECOLOGIC OR COMMUNITY
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: July 27, 2024
• First Posted: July 31, 2024
• Study Start: May 1, 2026
• Primary Completion (Estimated): April 30, 2029
• Study Completion (Estimated): April 30, 2030
• Last Updated: December 4, 2025

Record last verified: 2025-12

Data Sharing

• IPD Sharing: Will share
• Shared Documents: STUDY PROTOCOL, SAP
• Time Frame: 5/1/25 - 4/30/30

Locations

US (1)